Home » Topics » BioWorld Science

BioWorld Science
RSS

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

Enterome and Nestle Health Science collaborate to tackle food allergies and IBD

July 18, 2022

PCYOX1 identified as new target for antithrombotic therapy

July 18, 2022

Merck & Co. synthesizes orexin OX2 receptor agonists

July 18, 2022

Pfizer describes new IL-2 production inhibitors

July 18, 2022

Janssen Pharmaceutica presents new Mcl-1 inhibitors

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

Sunshine Lake Pharma patents new chymotrypsin inhibitors

July 18, 2022

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...